[HTML][HTML] Role of favipiravir in the treatment of COVID-19
S Joshi, J Parkar, A Ansari, A Vora, D Talwar… - International Journal of …, 2021 - Elsevier
Abstract The coronavirus disease-2019 (COVID-19) outbreak all over the world has led the
researchers to strive to develop drugs or vaccines to prevent or halt the progression of this …
researchers to strive to develop drugs or vaccines to prevent or halt the progression of this …
The proteins of severe acute respiratory syndrome coronavirus-2 (SARS CoV-2 or n-COV19), the cause of COVID-19
FK Yoshimoto - The protein journal, 2020 - Springer
The devastating effects of the recent global pandemic (termed COVID-19 for “coronavirus
disease 2019”) caused by the severe acute respiratory syndrome coronavirus-2 (SARS CoV …
disease 2019”) caused by the severe acute respiratory syndrome coronavirus-2 (SARS CoV …
Autoimmune and rheumatic musculoskeletal diseases as a consequence of SARS-CoV-2 infection and its treatment
Abstract The coronavirus disease-2019 (COVID-19) pandemic is likely to pose new
challenges to the rheumatology community in the near and distant future. Some of the …
challenges to the rheumatology community in the near and distant future. Some of the …
[PDF][PDF] The therapeutic potential of convalescent plasma therapy on treating critically-ill COVID-19 patients residing in respiratory care units in hospitals in Baghdad …
AM Rasheed, DF Fatak, HA Hashim, MF Maulood… - Infez Med, 2020 - infezmed.it
SUMMARY about 4 days and showed less death rate [1/21 versus 8/28 in control group]. In
addition, all the patients who were given convalescent plasma showed high levels of SARS …
addition, all the patients who were given convalescent plasma showed high levels of SARS …
[HTML][HTML] Gastrointestinal symptoms, pathophysiology, and treatment in COVID-19
Abstract The novel coronavirus Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-
CoV-2) has emerged and is responsible for the Coronavirus Disease 2019 global pandemic …
CoV-2) has emerged and is responsible for the Coronavirus Disease 2019 global pandemic …
Characteristics of viral pneumonia in the COVID-19 era: an update
Influenza virus, rhinovirus, and adenovirus frequently cause viral pneumonia, an important
cause of morbidity and mortality especially in the extreme ages of life. During the last two …
cause of morbidity and mortality especially in the extreme ages of life. During the last two …
Antibody-based immunotherapeutics and use of convalescent plasma to counter COVID-19: advances and prospects
ABSTRACT Introduction Coronavirus disease 2019 (COVID-19) has spread to several
countries globally. Currently, there is no specific drug or vaccine available for managing …
countries globally. Currently, there is no specific drug or vaccine available for managing …
Identification of drug interaction adverse events in patients with COVID-19: a systematic review
V Conti, C Sellitto, M Torsiello, V Manzo… - JAMA Network …, 2022 - jamanetwork.com
Importance During the COVID-19 pandemic, urgent clinical management of patients has
mainly included drugs currently administered for other diseases, referred to as repositioned …
mainly included drugs currently administered for other diseases, referred to as repositioned …
The COVID-19 research landscape: Measuring topics and collaborations using scientific literature
J Wang, N Hong - Medicine, 2020 - journals.lww.com
Objectives: The Coronavirus Disease 2019 (COVID-19) caused heavy burdens and brought
tremendous challenges to global public health. This study aimed to investigate collaboration …
tremendous challenges to global public health. This study aimed to investigate collaboration …
Natural and synthetic drugs as potential treatment for coronavirus disease 2019 (COVID-2019)
Abstract Coronavirus disease 2019 (COVID-19) has become a global pandemic in a short
period, where a tragically large number of human lives being lost. It is an infectious …
period, where a tragically large number of human lives being lost. It is an infectious …